| For: |
Babic Z, Svoboda-Beusan I, Kucisec-Tepes N, Dekaris D, Troskot R. Increased activity of Pgp multidrug transporter in patients with |
|---|---|
| URL: | https://www.wjgnet.com/1007-9327/full/v11/i18/2720.htm |
| Number | Citing Articles |
| 1 |
Inga Dietz, Stefan Jerchel, Márta Szaszák, Kensuke Shima, Jan Rupp. When oxygen runs short: the microenvironment drives host–pathogen interactions. Microbes and Infection 2012; 14(4) doi: 10.1016/j.micinf.2011.11.003
|
| 2 |
Marhanis OMAR, Andrew CROWE, Richard PARSONS, Hooi EE, Chin Yen TAY, Jeffery HUGHES. P‐glycoprotein expression in Helicobacter pylori‐positive patients: The influence of MDR1 C3435T polymorphism. Journal of Digestive Diseases 2012; 13(8) doi: 10.1111/j.1751-2980.2012.00606.x
|
| 3 |
Mei Zhang. High antibiotic resistance rate: A difficult issue for <i>Helicobacter pylori</i> eradication treatment. World Journal of Gastroenterology 2015; 21(48): 13432-13437 doi: 10.3748/wjg.v21.i48.13432
|
| 4 |
Noor Safwah Damanhuri, Endang Kumolosasi, Marhanis Salihah Omar, Amirul Faiz Abd Razak, Ahmad Hasnan Mansor. The influence of P-glycoprotein expression in the standard treatment of Helicobacter pylori infection in Sprague Dawley rats. DARU Journal of Pharmaceutical Sciences 2021; 29(1) doi: 10.1007/s40199-020-00377-2
|
| 5 |
Mitsushige Sugimoto, Takahisa Furuta, Naohito Shirai, Chise Kodaira, Masafumi Nishino, Mihoko Yamade, Mutsuhiro Ikuma, Haruhiko Sugimura, Takashi Ishizaki, Akira Hishida. MDR1 C3435T polymorphism has no influence on developing Helicobacter pylori infection-related gastric cancer and peptic ulcer in Japanese. Life Sciences 2008; 83(7-8) doi: 10.1016/j.lfs.2008.06.022
|
| 6 |
Ashutosh Gupta, Shiran Shetty, Srinivas Mutalik, Raghu Chandrashekar H, Nandakumar K, Elizabeth Mary Mathew, Abhishek Jha, Brahmeshwar Mishra, Siddheesh Rajpurohit, Gundawar Ravi, Moumita Saha, Sudheer Moorkoth. Treatment of H. pylori infection and gastric ulcer: Need for novel Pharmaceutical formulation. Heliyon 2023; 9(10) doi: 10.1016/j.heliyon.2023.e20406
|
| 7 |
Marhanis Omar, Andrew Crowe, Chin Yen Tay, Jeffery Hughes. Expressions of P-glycoprotein in treatment - Resistant Helicobacter pylori patients. Journal of Applied Biomedicine 2014; 12(4) doi: 10.1016/j.jab.2014.02.001
|
| 8 |
Nazanin Khazali, Paria Ghadersoltani, Parastoo Saniee.
Integrating host genetics in
Helicobacter pylori
infection: clinical insights for personalized eradication strategies
. Personalized Medicine 2026; 23(2) doi: 10.1080/17410541.2026.2653875
|
| 9 |
Susan M. Abdel-Rahman, Gordon L. Amidon, Ajay Kaul, Viera Lukacova, Alexander A. Vinks, Gregory T. Knipp. Summary of the National Institute of Child Health and Human Development–Best Pharmaceuticals for Children Act Pediatric Formulation Initiatives Workshop–Pediatric Biopharmaceutics Classification System Working Group. Clinical Therapeutics 2012; 34(11) doi: 10.1016/j.clinthera.2012.09.014
|
| 10 |
Brandon J. Kim, Maura A. McDonagh, Liwen Deng, Benjamin D. Gastfriend, Alexandra Schubert-Unkmeir, Kelly S. Doran, Eric V. Shusta. Streptococcus agalactiae disrupts P-glycoprotein function in brain endothelial cells. Fluids and Barriers of the CNS 2019; 16(1) doi: 10.1186/s12987-019-0146-5
|